Volume 5 Number 4
Editorials
63
Stent selection in patients on oral anticoagulants: can we prevent restenosis and avoid bleeding?EuroIntervention 2009;5:405-407
64
Meta-analytic rage or race for evidence-based interventional cardiology?EuroIntervention 2009;5:409-413
EAPCI column
Clinical research
66
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trialEuroIntervention 2009;5:417-424
67
Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulant therapyEuroIntervention 2009;5:425-431
68
Long-term follow-up after drug eluting stent implantation in left main trifurcationsEuroIntervention 2009;5:432-437
69
Aorto-iliac angiography as a screening tool in selecting patients for transfemoral aortic valve implantation with the Edwards SAPIEN bioprosthesisEuroIntervention 2009;5:438-442
70
The recurrence of iatrogenic femoral artery pseudoaneurysm after occlusion by ultrasound guided percutaneous thrombin injectionEuroIntervention 2009;5:443-447
71
Comparison of the very long term (>1 year) outcomes of drug-eluting stents for the treatment of bare-metal and drug-eluting stent restenosisEuroIntervention 2009;5:448-453
72
Long-term clinical outcome of alternative treatment strategies for drug-eluting stents restenosisEuroIntervention 2009;5:454:459
73
Impact of drug eluting stents on the clinical practice of revascularisation of coronary artery diseaseEuroIntervention 2009;5:460-464
74
Assisted circulation using the Tandemheart®, percutaneous transseptal left ventricular assist device, during percutaneous aortic valve implantation: the Rotterdam experienceEuroIntervention 2009;5:465-469
75
A novel strategy for managing clopidogrel-induced adverse skin reactionsEuroIntervention 2009;5:470-474
Expert review
76
Bifurcation stenting with drug-eluting stents: a systematic review and meta-analysis of randomised trialsEuroIntervention 2009;5:475-484
77
Directional coronary atherectomy: a time for reflection. Should we let it go?EuroIntervention 2009;5:485-493
78
The use of drug-eluting stents in ST-elevation myocardial infarctionEuroIntervention 2009;5:494-500
80
Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stentsEuroIntervention 2009;5:505-510
EuroIntervention Tools & Techniques
Technical report
82
Virtual 3 Fr PCI system for complex percutaneous coronary interventionEuroIntervention 2009;5:515-517
Volume 5 Number 4 has been released thanks to the support of the following partners:
- Abbott Vascular Devices
- Cordis, a Johnson & Johnson company
- Daiichi Sankyo
- Hexacath
- Maquet Cardiovascular
- Medtronic
- Minvasys
- Terumo



